EQL Pharma AB

XSAT:EQL (Sweden)  
kr 39.20 (0%) Feb 29
40.00
P/B:
6.58
Market Cap:
kr 1.14B ($ 109.89M)
Enterprise V:
kr 1.24B ($ 119.13M)
Volume:
3.20K
Avg Vol (2M):
23.14K
Also Trade In:
Volume:
3.20K
Avg Vol (2M):
23.14K

Business Description

Description
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.
Name Current Vs Industry Vs History
Cash-To-Debt 0.1
Equity-to-Asset 0.51
Debt-to-Equity 0.61
Debt-to-EBITDA 3.32
Interest Coverage 7.24
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.22
Distress
Grey
Safe
Beneish M-Score -2.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.18
9-Day RSI 68.75
14-Day RSI 66.2
6-1 Month Momentum % 22.38
12-1 Month Momentum % -6.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.28
Quick Ratio 0.56
Cash Ratio 0.08
Days Inventory 209.11
Days Sales Outstanding 82.65
Days Payable 84.87

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.15

Financials (Next Earnings Date:2024-05-14)

XSAT:EQL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

EQL Pharma AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr) 246.367
EPS (TTM) (kr) 0.98
Beta 0.78
Volatility % 43.93
14-Day RSI 66.2
14-Day ATR (kr) 1.450739
20-Day SMA (kr) 37.165
12-1 Month Momentum % -6.67
52-Week Range (kr) 24.7 - 40.5
Shares Outstanding (Mil) 29.06

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

EQL Pharma AB Filings

Filing Date Document Date Form
No Filing Data

EQL Pharma AB Stock Events

Financials Calendars
Event Date Price(kr)
No Event Data

EQL Pharma AB Frequently Asked Questions

What is EQL Pharma AB(XSAT:EQL)'s stock price today?
The current price of XSAT:EQL is kr39.20. The 52 week high of XSAT:EQL is kr40.50 and 52 week low is kr24.70.
When is next earnings date of EQL Pharma AB(XSAT:EQL)?
The next earnings date of EQL Pharma AB(XSAT:EQL) is 2024-05-14.
Does EQL Pharma AB(XSAT:EQL) pay dividends? If so, how much?
EQL Pharma AB(XSAT:EQL) does not pay dividend.

Press Release

Subject Date
No Press Release